Trial Profile
A 52-week prospective cohort study of adalimumab in patients with psoriatic arthritis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Psoriatic arthritis
- Focus Pharmacokinetics; Therapeutic Use
- 02 Sep 2015 New trial record